XCL1 and neoplasm: To understand why the combination of the Xcl1-E6E7+mIL-9 DNA vaccine and PD-1 inhibitor is ineffective, further investigation is required to assess whether the tumor-specific T cells induced by the DNA vaccine are in a PD-1-responsive state.